TrialThe journal of headache and pain2025

Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab.

Hans-Christoph Diener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.